Entrada Therapeutics Inc. (TRDA)
undefined
undefined%
At close: undefined
17.66
-0.11%
After-hours Dec 13, 2024, 04:00 PM EST

Entrada Therapeutics Inc. Forcast

Stock Price Forecast

The 3 analysts with 12-month price forecasts for TRDA stock have an median target of 28, with a low estimate of 20 and a high estimate of 29. The median target predicts an increase of 58.37% from the current stock price of 17.68.

Analyst Consensus: Buy
Target Low Average Median High
Price $20 $25.67 $28 $29
Change 13.12% 45.19% 58.37% 64.03%

AI Analyst Report

HC Wainwright & Co. maintains a Buy rating on Entr... Unlock content with Pro Subscription

Updated Nov 06, 2024

Rating Jan 24Mar 24Jun 24Aug 24Nov 24Dec 24
Strong Buy 000010
Buy 111211
Hold 000000
Sell 000000
Strong Sell 000000
Total 1 1 1 2 2 1

Financial Forecast this Year

Revenue This Year
175.88M
from 129.01M
Increased by 36.3%
Revenue Next Year
39.88M
from 175.88M
Increased by -77.3%
EPS This Year
0.45
from -0.2
Increased by -125%
EPS Next Year
-3.95
from 0.45
Increased by -777.8%